Sophia M. Nevin, n/a

Mayo Clinic Rochester
Rochester, Minnesota, United States

Disclosure information not submitted.

Presentation(s):

• MON-506 - Safety and Clinical Impact of Overnight Metyrapone in Mild Autonomous Cortisol Secretion: An Open-Label Phase 2 Trial

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT